MDT logo

Medtronic plc (MDT) EBITDA

annual EBITDA:

$9.05B+$675.00M(+8.06%)
April 25, 2025

Summary

  • As of today (August 20, 2025), MDT annual EBITDA is $9.05 billion, with the most recent change of +$675.00 million (+8.06%) on April 25, 2025.
  • During the last 3 years, MDT annual EBITDA has risen by +$159.00 million (+1.79%).
  • MDT annual EBITDA is now -7.21% below its all-time high of $9.76 billion, reached on April 26, 2019.

Performance

1-year change

+8.06%

3-year change

+1.79%

5-year change

+20.06%

15-year change

-2.54%

MDT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.53%
MDT annual EBITDA is higher than 98.53% of companies in Healthcare sector

Range

All-time high

$9.76B
MDT annual EBITDA is currently -7.21% below its historical high of $9.76 billion

3-year low

$8.21B
MDT annual EBITDA is currently +10.31% above its 3-year low

Earnings dates

Last annual earnings report date

Apr 25, 2025
MDT previous annual earnings announcement was published on Apr 25, 2025

Next annual earnings report date

N/A
MDT next annual earnings announcement has not yet been scheduled

OtherMDTincome statement metrics

Annual revenue

$33.54B
MDT annual revenue is $33.54 billion

annual net income

$4.69B
MDT annual net profit is $4.69 billion

annual EBIT

$6.19B
MDT annual earnings before interest & taxes is $6.19 billion

Annual EPS

$3.61
MDT annual earnings per share is $3.61

quarterly EBITDA:

$2.39B+$48.00M(+2.05%)
July 1, 2025

Summary

  • As of today (August 20, 2025), MDT quarterly EBITDA is $2.39 billion, with the most recent change of +$48.00 million (+2.05%) on July 1, 2025.
  • Over the past year, MDT quarterly EBITDA has increased by +$363.00 million (+17.93%).
  • MDT quarterly EBITDA is now -15.08% below its all-time high of $2.81 billion, reached on April 27, 2018.

Performance

3-month change

+2.05%

1-year change

+17.93%

3-year change

+37.32%

5-year change

+84.26%

MDT quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.26%
MDT quarterly EBITDA is higher than 98.26% of companies in Healthcare sector

Range

All-time high

$2.81B
MDT quarterly EBITDA is currently -15.08% below its historical high of $2.81 billion

3-year low

$1.74B
MDT quarterly EBITDA is currently +37.32% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jul 1, 2025
MDT previous earnings announcement was published on Jul 1, 2025

Next quarterly earnings report date

N/A
MDT next earnings announcement has not yet been scheduled

OtherMDTincome statement metrics

Quarterly revenue

$8.58B
MDT quarterly revenue is $8.58 billion

quarterly net income

$1.05B
MDT quarterly net profit is $1.05 billion

quarterly EBIT

$1.64B
MDT quarterly earnings before interest & taxes is $1.64 billion

Quarterly EPS

$0.81
MDT quarterly earnings per share is $0.81

TTM EBITDA:

$9.39B+$363.00M(+4.02%)
July 1, 2025

Summary

  • As of today (August 20, 2025), MDT TTM EBITDA is $9.39 billion, with the most recent change of +$363.00 million (+4.02%) on July 1, 2025.
  • Over the past year, MDT TTM EBITDA has increased by +$904.00 million (+10.66%).
  • MDT TTM EBITDA is now -4.68% below its all-time high of $9.85 billion, reached on January 25, 2019.

Performance

3-month change

+4.02%

1-year change

+10.66%

3-year change

+5.15%

5-year change

+41.07%

MDT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.34%
MDT TTM EBITDA is higher than 98.34% of companies in Healthcare sector

Range

All-time high

$9.85B
MDT TTM EBITDA is currently -4.68% below its historical high of $9.85 billion

3-year low

$8.12B
MDT TTM EBITDA is currently +15.69% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jul 1, 2025
MDT previous earnings announcement was published on Jul 1, 2025

Next quarterly earnings report date

N/A
MDT next earnings announcement has not yet been scheduled

OtherMDTincome statement metrics

TTM revenue

$34.20B
MDT TTM revenue is $34.20 billion

TTM net income

$4.69B
MDT TTM net profit is $4.69 billion

TTM EBIT

$6.44B
MDT TTM earnings before interest & taxes is $6.44 billion

TTM EPS

$3.63
MDT TTM earnings per share is $3.63

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$9.05B
MDT annual EBITDA is $9.05 billion

annual net income

$4.69B
MDT annual net profit is $4.69 billion

annual interest expense

$0.00
MDT annual interest expense is $0.00

annual income tax

$936.00M
MDT annual income tax is $936.00 million

annual D&A

$2.86B
MDT annual depreciation & amortization is $2.86 billion

MDT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.1%+17.9%+10.7%
3 y3 years+1.8%+37.3%+5.2%
5 y5 years+20.1%+84.3%+41.1%

MDT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+10.3%-0.8%+37.3%at high+15.7%
5 y5-yearat high+20.1%-7.7%+84.3%at high+41.1%
alltimeall time-7.2%>+9999.0%-15.1%+676.7%-4.7%+6815.3%

MDT EBITDA History

DateAnnualQuarterlyTTM
Jul 2025
-
$2.39B(+2.1%)
$9.39B(+4.0%)
Apr 2025
$9.05B(+8.1%)
$2.34B(-2.8%)
$9.03B(+1.8%)
Jan 2025
-
$2.41B(+6.8%)
$8.87B(+3.6%)
Oct 2024
-
$2.25B(+11.3%)
$8.55B(+0.8%)
Jul 2024
-
$2.02B(-7.2%)
$8.48B(+0.4%)
Apr 2024
-
$2.18B(+4.1%)
$8.45B(-2.3%)
Apr 2024
$8.38B(+2.1%)
-
-
Jan 2024
-
$2.10B(-3.9%)
$8.65B(+1.7%)
Oct 2023
-
$2.18B(+9.5%)
$8.51B(+1.7%)
Jul 2023
-
$1.99B(-16.4%)
$8.37B(+3.1%)
Apr 2023
-
$2.38B(+22.0%)
$8.12B(-0.2%)
Apr 2023
$8.21B(-7.7%)
-
-
Jan 2023
-
$1.95B(-4.4%)
$8.13B(-5.8%)
Oct 2022
-
$2.04B(+17.4%)
$8.64B(-3.3%)
Jul 2022
-
$1.74B(-27.5%)
$8.93B(+1.0%)
Apr 2022
$8.89B(+10.1%)
$2.40B(-2.3%)
$8.84B(-1.6%)
Jan 2022
-
$2.46B(+5.2%)
$8.99B(-1.4%)
Oct 2021
-
$2.33B(+41.5%)
$9.12B(+1.9%)
Jul 2021
-
$1.65B(-35.3%)
$8.95B(+4.1%)
Apr 2021
$8.08B(+7.2%)
$2.55B(-1.5%)
$8.60B(+27.2%)
Jan 2021
-
$2.59B(+19.3%)
$6.76B(-0.8%)
Oct 2020
-
$2.17B(+67.2%)
$6.81B(+2.4%)
Jul 2020
-
$1.30B(+83.1%)
$6.66B(-12.7%)
Apr 2020
$7.54B(-22.7%)
$708.00M(-73.2%)
$7.62B(-21.2%)
Jan 2020
-
$2.64B(+31.4%)
$9.67B(+2.5%)
Oct 2019
-
$2.01B(-11.2%)
$9.43B(-3.4%)
Jul 2019
-
$2.26B(-17.9%)
$9.77B(-0.3%)
Apr 2019
$9.76B(+5.0%)
$2.76B(+14.7%)
$9.79B(-0.6%)
Jan 2019
-
$2.40B(+2.6%)
$9.85B(+0.8%)
Oct 2018
-
$2.34B(+2.2%)
$9.77B(+3.0%)
Jul 2018
-
$2.29B(-18.5%)
$9.48B(+0.9%)
Apr 2018
$9.29B(-2.1%)
$2.81B(+21.2%)
$9.39B(+2.1%)
Jan 2018
-
$2.32B(+13.1%)
$9.20B(-0.1%)
Oct 2017
-
$2.05B(-6.9%)
$9.21B(-2.4%)
Jul 2017
-
$2.21B(-15.9%)
$9.44B(+0.4%)
Apr 2017
$9.49B(+6.2%)
$2.62B(+12.5%)
$9.40B(+1.5%)
Jan 2017
-
$2.33B(+2.1%)
$9.27B(+4.2%)
Oct 2016
-
$2.28B(+5.1%)
$8.89B(+3.0%)
Jul 2016
-
$2.17B(-12.7%)
$8.63B(+4.1%)
Apr 2016
$8.93B(+47.4%)
$2.49B(+27.1%)
$8.30B(+10.7%)
Jan 2016
-
$1.96B(-3.3%)
$7.49B(+13.2%)
Oct 2015
-
$2.02B(+10.4%)
$6.62B(+12.7%)
Jul 2015
-
$1.83B(+8.8%)
$5.87B(+8.1%)
Apr 2015
$6.06B(+9.4%)
$1.68B(+55.9%)
$5.43B(+2.7%)
Jan 2015
-
$1.08B(-15.2%)
$5.29B(-3.3%)
Oct 2014
-
$1.27B(-8.3%)
$5.47B(-2.1%)
Jul 2014
-
$1.39B(-9.8%)
$5.58B(+1.7%)
Apr 2014
$5.54B(+1.7%)
$1.54B(+22.2%)
$5.49B(-0.5%)
Jan 2014
-
$1.26B(-9.5%)
$5.52B(-0.9%)
Oct 2013
-
$1.39B(+7.2%)
$5.57B(+0.3%)
Jul 2013
-
$1.30B(-17.0%)
$5.55B(+1.2%)
Apr 2013
$5.45B(+3.5%)
$1.57B(+19.5%)
$5.48B(+0.1%)
Jan 2013
-
$1.31B(-4.7%)
$5.48B(+0.4%)
Oct 2012
-
$1.38B(+11.5%)
$5.46B(+2.1%)
Jul 2012
-
$1.23B(-21.1%)
$5.35B(-1.9%)
Apr 2012
$5.26B(+0.6%)
$1.56B(+21.4%)
$5.45B(+1.0%)
Jan 2012
-
$1.29B(+1.8%)
$5.40B(+2.0%)
Oct 2011
-
$1.26B(-5.3%)
$5.29B(-1.7%)
Jul 2011
-
$1.34B(-11.5%)
$5.39B(+1.7%)
Apr 2011
$5.23B(-5.4%)
$1.51B(+27.6%)
$5.30B(-0.1%)
Jan 2011
-
$1.18B(-13.0%)
$5.30B(-1.9%)
Oct 2010
-
$1.36B(+9.2%)
$5.40B(+0.9%)
Jul 2010
-
$1.25B(-17.9%)
$5.36B(-2.0%)
Apr 2010
$5.53B(+16.6%)
$1.52B(+18.2%)
$5.47B(+4.0%)
Jan 2010
-
$1.28B(-2.2%)
$5.26B(+1.6%)
Oct 2009
-
$1.31B(-3.3%)
$5.18B(+3.0%)
Jul 2009
-
$1.36B(+3.7%)
$5.02B(+1.4%)
Apr 2009
$4.74B(+7.1%)
$1.31B(+9.1%)
$4.95B(+0.9%)
Jan 2009
-
$1.20B(+3.5%)
$4.91B(+2.9%)
Oct 2008
-
$1.16B(-9.9%)
$4.77B(+5.0%)
Jul 2008
-
$1.29B(+1.9%)
$4.54B(+6.0%)
Apr 2008
$4.42B(+8.0%)
$1.26B(+19.0%)
$4.29B(+3.7%)
Jan 2008
-
$1.06B(+13.6%)
$4.13B(+0.6%)
Oct 2007
-
$934.00M(-9.4%)
$4.11B(-1.8%)
Jul 2007
-
$1.03B(-6.9%)
$4.19B(+1.8%)
Apr 2007
$4.10B(+2.7%)
$1.11B(+6.9%)
$4.11B(+0.2%)
Jan 2007
-
$1.04B(+2.5%)
$4.10B(+0.4%)
Oct 2006
-
$1.01B(+5.8%)
$4.09B(+0.5%)
Jul 2006
-
$956.00M(-13.2%)
$4.07B(-0.3%)
Apr 2006
$3.99B(+6.4%)
$1.10B(+8.0%)
$4.08B(+2.2%)
Jan 2006
-
$1.02B(+2.7%)
$3.99B(+3.3%)
Oct 2005
-
$992.60M(+2.6%)
$3.86B(+3.5%)
Jul 2005
-
$967.60M(-4.4%)
$3.73B(+3.2%)
Apr 2005
$3.75B
$1.01B(+13.6%)
$3.62B(-1.4%)
Jan 2005
-
$890.90M(+3.5%)
$3.67B(+0.2%)
Oct 2004
-
$861.00M(+1.1%)
$3.66B(-0.1%)
DateAnnualQuarterlyTTM
Jul 2004
-
$851.90M(-19.8%)
$3.66B(+1.2%)
Apr 2004
$3.62B(+31.3%)
$1.06B(+20.0%)
$3.62B(+7.7%)
Jan 2004
-
$884.80M(+2.1%)
$3.36B(+5.2%)
Oct 2003
-
$866.30M(+7.2%)
$3.20B(+4.1%)
Jul 2003
-
$808.10M(+0.7%)
$3.07B(+13.3%)
Apr 2003
$2.76B(+11.3%)
$802.20M(+11.5%)
$2.71B(+2.7%)
Jan 2003
-
$719.30M(-2.9%)
$2.64B(+4.2%)
Oct 2002
-
$740.80M(+65.8%)
$2.53B(+9.9%)
Jul 2002
-
$446.70M(-38.9%)
$2.30B(-4.7%)
Apr 2002
$2.48B(+13.5%)
$731.40M(+19.4%)
$2.42B(+5.6%)
Jan 2002
-
$612.50M(+19.3%)
$2.29B(+2.6%)
Oct 2001
-
$513.50M(-8.5%)
$2.23B(-0.3%)
Jul 2001
-
$561.20M(-7.0%)
$2.24B(+2.5%)
Apr 2001
$2.18B(+16.8%)
$603.30M(+8.7%)
$2.19B(+4.2%)
Jan 2001
-
$555.20M(+6.5%)
$2.10B(+6.3%)
Oct 2000
-
$521.20M(+3.0%)
$1.97B(+2.7%)
Jul 2000
-
$505.80M(-1.7%)
$1.92B(+5.0%)
Apr 2000
$1.87B(+35.1%)
$514.70M(+19.4%)
$1.83B(+6.0%)
Jan 2000
-
$431.10M(-8.1%)
$1.73B(+2.0%)
Oct 1999
-
$469.30M(+13.1%)
$1.69B(+14.6%)
Jul 1999
-
$415.10M(+1.0%)
$1.48B(+12.0%)
Apr 1999
$1.38B(+36.1%)
$411.10M(+3.5%)
$1.32B(+10.7%)
Jan 1999
-
$397.29M(+56.3%)
$1.19B(+16.0%)
Oct 1998
-
$254.19M(-1.0%)
$1.03B(+0.8%)
Jul 1998
-
$256.88M(-9.5%)
$1.02B(+0.2%)
Apr 1998
$1.02B(+12.9%)
$283.71M(+21.7%)
$1.02B(-8.7%)
Jan 1998
-
$233.15M(-5.2%)
$1.11B(+1.5%)
Oct 1997
-
$245.84M(-3.4%)
$1.10B(+2.3%)
Jul 1997
-
$254.49M(-33.2%)
$1.07B(+2.7%)
Apr 1997
$901.37M(+18.8%)
$380.80M(+76.0%)
$1.05B(+21.8%)
Jan 1997
-
$216.40M(-2.3%)
$858.50M(+3.4%)
Oct 1996
-
$221.40M(-2.3%)
$830.00M(+4.7%)
Jul 1996
-
$226.70M(+16.9%)
$792.50M(+5.7%)
Apr 1996
$758.95M(+39.8%)
$194.00M(+3.2%)
$749.70M(+5.1%)
Jan 1996
-
$187.90M(+2.2%)
$713.10M(+8.8%)
Oct 1995
-
$183.90M(0.0%)
$655.20M(+9.5%)
Jul 1995
-
$183.90M(+16.8%)
$598.10M(+10.2%)
Apr 1995
$542.84M(+32.0%)
$157.40M(+21.1%)
$542.70M(+7.6%)
Jan 1995
-
$130.00M(+2.5%)
$504.20M(+5.6%)
Oct 1994
-
$126.80M(-1.3%)
$477.50M(+4.5%)
Jul 1994
-
$128.50M(+8.1%)
$457.00M(+11.1%)
Apr 1994
$411.25M(+12.8%)
$118.90M(+15.1%)
$411.30M(+3.5%)
Jan 1994
-
$103.30M(-2.8%)
$397.30M(+4.3%)
Oct 1993
-
$106.30M(+28.4%)
$380.90M(+5.7%)
Jul 1993
-
$82.80M(-21.1%)
$360.40M(-1.4%)
Apr 1993
$364.74M(+19.4%)
$104.90M(+20.7%)
$365.40M(+1.5%)
Jan 1993
-
$86.90M(+1.3%)
$360.00M(+5.1%)
Oct 1992
-
$85.80M(-2.3%)
$342.60M(+4.4%)
Jul 1992
-
$87.80M(-11.8%)
$328.10M(+7.4%)
Apr 1992
$305.40M(+23.7%)
$99.50M(+43.2%)
$305.40M(+8.9%)
Jan 1992
-
$69.50M(-2.5%)
$280.40M(+3.0%)
Oct 1991
-
$71.30M(+9.5%)
$272.20M(+5.5%)
Jul 1991
-
$65.10M(-12.6%)
$258.00M(+4.5%)
Apr 1991
$246.87M(+20.8%)
$74.50M(+21.5%)
$247.00M(+8.8%)
Jan 1991
-
$61.30M(+7.4%)
$227.00M(+4.3%)
Oct 1990
-
$57.10M(+5.5%)
$217.60M(+3.6%)
Jul 1990
-
$54.10M(-0.7%)
$210.10M(-39.6%)
Apr 1990
$204.33M(+17.2%)
$54.50M(+5.0%)
$347.90M(-388.2%)
Jan 1990
-
$51.90M(+4.6%)
-$120.70M(-950.0%)
Oct 1989
-
$49.60M(-74.2%)
$14.20M(-90.3%)
Jul 1989
-
$191.90M(-146.3%)
$145.80M(+12.4%)
Apr 1989
$174.31M(+9.5%)
-$414.10M(-321.7%)
$129.70M(-38.2%)
Jan 1989
-
$186.80M(+3.1%)
$209.80M(+10.2%)
Oct 1988
-
$181.20M(+3.1%)
$190.30M(+18.0%)
Jul 1988
-
$175.80M(-152.6%)
$161.30M(+24.0%)
Apr 1988
$159.13M(+20.4%)
-$334.00M(-299.6%)
$130.10M(-38.5%)
Jan 1988
-
$167.30M(+9.9%)
$211.70M(+27.4%)
Oct 1987
-
$152.20M(+5.3%)
$166.20M(+23.9%)
Jul 1987
-
$144.60M(-157.3%)
$134.10M(+26.9%)
Apr 1987
$132.13M(+32.6%)
-$252.40M(-307.2%)
$105.70M(-25.9%)
Jan 1987
-
$121.80M(+1.4%)
$142.70M(+17.9%)
Oct 1986
-
$120.10M(+3.4%)
$121.00M(+19.1%)
Jul 1986
-
$116.20M(-153.9%)
$101.60M(+21.8%)
Apr 1986
$99.66M(+55.4%)
-$215.40M(-315.2%)
$83.40M(+95.3%)
Jan 1986
-
$100.10M(-0.6%)
$42.70M(+12.4%)
Oct 1985
-
$100.70M(+2.8%)
$38.00M(+4.7%)
Jul 1985
-
$98.00M(-138.3%)
$36.30M(-5.7%)
Apr 1985
$64.11M(-29.6%)
-$256.10M(-368.4%)
$38.50M(-25.5%)
Jan 1985
-
$95.40M(-3.6%)
$51.70M(-13.0%)
Oct 1984
-
$99.00M(-1.2%)
$59.40M(-250.0%)
Jul 1984
-
$100.20M(-141.3%)
-$39.60M(-71.7%)
Apr 1984
$91.10M(+0.4%)
-$242.90M(-335.6%)
-$139.80M(-235.6%)
Jan 1984
-
$103.10M
$103.10M
Apr 1983
$90.72M(+20.3%)
-
-
Apr 1982
$75.44M(+8.8%)
-
-
Apr 1981
$69.34M(+14.6%)
-
-
Apr 1980
$60.49M
-
-

FAQ

  • What is Medtronic plc annual EBITDA?
  • What is the all time high annual EBITDA for Medtronic plc?
  • What is Medtronic plc annual EBITDA year-on-year change?
  • What is Medtronic plc quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Medtronic plc?
  • What is Medtronic plc quarterly EBITDA year-on-year change?
  • What is Medtronic plc TTM EBITDA?
  • What is the all time high TTM EBITDA for Medtronic plc?
  • What is Medtronic plc TTM EBITDA year-on-year change?

What is Medtronic plc annual EBITDA?

The current annual EBITDA of MDT is $9.05B

What is the all time high annual EBITDA for Medtronic plc?

Medtronic plc all-time high annual EBITDA is $9.76B

What is Medtronic plc annual EBITDA year-on-year change?

Over the past year, MDT annual EBITDA has changed by +$675.00M (+8.06%)

What is Medtronic plc quarterly EBITDA?

The current quarterly EBITDA of MDT is $2.39B

What is the all time high quarterly EBITDA for Medtronic plc?

Medtronic plc all-time high quarterly EBITDA is $2.81B

What is Medtronic plc quarterly EBITDA year-on-year change?

Over the past year, MDT quarterly EBITDA has changed by +$363.00M (+17.93%)

What is Medtronic plc TTM EBITDA?

The current TTM EBITDA of MDT is $9.39B

What is the all time high TTM EBITDA for Medtronic plc?

Medtronic plc all-time high TTM EBITDA is $9.85B

What is Medtronic plc TTM EBITDA year-on-year change?

Over the past year, MDT TTM EBITDA has changed by +$904.00M (+10.66%)
On this page